These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31933519)

  • 41. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes.
    Zhang Z; Xu L; Sun C
    Oncol Lett; 2018 Feb; 15(2):1503-1510. PubMed ID: 29434842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
    Lin X; Chen Y
    Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.
    Wen DY; Huang JC; Wang JY; Pan WY; Zeng JH; Pang YY; Yang H
    Oncol Lett; 2018 Dec; 16(6):6918-6929. PubMed ID: 30546424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
    Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression.
    Yu L; Xu F; Gao L
    Front Bioeng Biotechnol; 2020; 8():8. PubMed ID: 32047745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
    Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
    Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
    Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
    Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High expression of NME1 correlates with progression and poor prognosis in patients of hepatocellular carcinoma.
    Yang J; Lv Z; Huang J; Zhao Y; Li Y
    Int J Clin Exp Pathol; 2017; 10(8):8561-8568. PubMed ID: 31966710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
    Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
    J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.
    Liang HW; Ye ZH; Yin SY; Mo WJ; Wang HL; Zhao JC; Liang GM; Feng ZB; Chen G; Luo DZ
    Onco Targets Ther; 2017; 10():3405-3419. PubMed ID: 28744145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas.
    Ye ZH; Gao L; Wen DY; He Y; Pang YY; Chen G
    Onco Targets Ther; 2017; 10():1711-1723. PubMed ID: 28356759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
    Azer SA
    J Clin Med; 2018 Mar; 7(4):. PubMed ID: 29584707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
    He RQ; Yang X; Liang L; Chen G; Ma J
    Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
    Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
    J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.